Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Covers the decline of cancer death rates, conventional and targeted anticancer drugs, surgical oncology, radiotherapy, chemotherapy, resistance mechanisms, and the history of targeted drugs and EGFR targeting.
Explores data privacy challenges and perspectives in eHealth research, focusing on GDPR compliance, sensitive health data management, and decentralized agents.
Covers the evasion of immune pressure by tumors, cancer immunotherapies, drug delivery strategies, and the impact of nanoparticle characteristics on tumor penetration.
Explores molecular glues as new drug modalities, focusing on binding forces, energetics, biomolecular interactions, quantification, drug development, and structural characterization.
Explores tumor immune evasion, drug delivery challenges, and nanoparticle strategies in cancer treatment, including the impact of checkpoint inhibitors and hydrogels.
Explores cancer therapies, including chemotherapies and targeted therapies, discussing mechanisms of action, limitations, and the development of resistance.
Delves into identifying drug targets, ensuring efficacy, and maintaining safety in medical chemistry, covering genetic tests, chirality, stereochemistry, drug resistance, and drug-likeness rules.
Explores the complexity of cancer, challenges in research translation, and the applications of tissue engineering for cancer models and drug screening.
Discusses the critical need for drug concentration monitoring in personalized medicine, covering classes of medical treatments, in vitro ligand selection, DNA aptamers, and microsample analytics.
